Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Multiple System Atrophy
NCT03589976Phase 2Terminated
- Sponsor
- NYU Langone Health
- Start
- Sep 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in multiple system atrophy (MSA), sponsored by NYU Langone Health. Started Sep 2018; status: terminated.
02
Drugs
sirolimus
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT03589976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03589976.